FRI-PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FRI-PHARMA
Largest movements
- Receivables within one year +€454,827
up €454,827 (+5.9%), from €7.7m to €8.1m
of which Trade receivables: +€265,802
- Profit (loss) carried forward +€239,063
up €239,063 (+18.1%), from €1.3m to €1.6m
- Trade debts +€141,178
up €141,178 (+48.4%), from €291,907 to €433,085
- Gross operating margin -€891,189
down €891,189, from €819,219 to -€71,970
- Staff costs -€544,739
down €544,739 (-100.0%), from €545,008 to €269
- Taxes -€120,144
down €120,144 (-78.0%), from €154,014 to €33,870
- Financial income -€67,264
down €67,264 (-16.1%), from €417,676 to €350,412
- Other operating charges -€40,375
down €40,375 (-96.5%), from €41,860 to €1,484
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €7,844,550 | €8,203,203 | +€358,653 | +4.6% |
| Formation expenses | 20 | €0 | - | = | |
| Fixed assets | 21/28 | €226 | - | -€226 | |
| Intangible fixed assets | 21 | €0 | - | = | |
| Tangible fixed assets | 22/27 | €226 | - | -€226 | |
| Plant, machinery and equipment | 23 | €226 | - | -€226 | |
| Furniture and vehicles | 24 | €0 | - | -€0 | |
| Leasing and similar rights | 25 | €0 | - | = | |
| Current assets | 29/58 | €7,844,323 | €8,203,203 | +€358,880 | +4.6% |
| Amounts receivable within one year | 40/41 | €7,669,786 | €8,124,613 | +€454,827 | +5.9% |
| Trade receivables | 40 | €48,746 | €314,548 | +€265,802 | +545% |
| Other amounts receivable | 41 | €7,621,041 | €7,810,065 | +€189,025 | +2.5% |
| Cash at bank and in hand | 54/58 | €157,942 | €78,539 | -€79,403 | -50.3% |
| Deferred charges and accrued income | 490/1 | €16,595 | €50 | -€16,545 | -99.7% |
| Total equity and liabilities | 10/49 | €7,844,550 | €8,203,203 | +€358,653 | +4.6% |
| Equity | 10/15 | €6,056,838 | €6,295,902 | +€239,063 | +3.9% |
| Contributions | 10/11 | €377,770 | €377,770 | = | 0.0% |
| Capital | 10 | €377,770 | €377,770 | = | 0.0% |
| Issued capital | 100 | €377,770 | €377,770 | = | 0.0% |
| Reserves | 13 | €4,355,425 | €4,355,425 | = | 0.0% |
| Non-distributable reserves | 130/1 | €37,777 | €37,777 | = | 0.0% |
| Legal reserve | 130 | €37,777 | €37,777 | = | 0.0% |
| Tax-exempt reserves | 132 | €4,317,648 | €4,317,648 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,323,643 | €1,562,706 | +€239,063 | +18.1% |
| Provisions and deferred taxes | 16 | €1,439,216 | €1,439,216 | = | 0.0% |
| Deferred taxes | 168 | €1,439,216 | €1,439,216 | = | 0.0% |
| Amounts payable | 17/49 | €348,495 | €468,085 | +€119,590 | +34.3% |
| Amounts payable after more than one year | 17 | €0 | - | = | |
| Financial debts | 170/4 | €0 | - | = | |
| Amounts payable within one year | 42/48 | €348,495 | €468,085 | +€119,590 | +34.3% |
| Current portion of amounts payable after more than one year | 42 | €9,850 | - | -€9,850 | |
| Financial debts | 43 | - | €35,000 | +€35,000 | |
| Credit institutions | 430/8 | - | €35,000 | +€35,000 | |
| Trade debts | 44 | €291,907 | €433,085 | +€141,178 | +48.4% |
| Suppliers | 440/4 | €291,907 | €433,085 | +€141,178 | +48.4% |
| Taxes, remuneration and social security | 45 | €46,738 | - | -€46,738 | |
| Taxes | 450/3 | €20,621 | - | -€20,621 | |
| Remuneration and social security | 454/9 | €26,117 | - | -€26,117 | |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Non-recurring operating income | 76A | €26,346 | - | -€26,346 | |
| Remuneration, social security and pensions | 62 | €545,008 | €269 | -€544,739 | -100.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €22,118 | €226 | -€21,892 | -99.0% |
| Other operating charges | 640/8 | €41,860 | €1,484 | -€40,375 | -96.5% |
| Non-recurring operating charges | 66A | €53,375 | - | -€53,375 | |
| Gross operating margin | 9900 | €819,219 | -€71,970 | -€891,189 | |
| Operating profit (loss) | 9901 | €156,858 | -€73,950 | -€230,808 | |
| Financial income | 75/76B | €417,676 | €350,412 | -€67,264 | -16.1% |
| Recurring financial income | 75 | €417,676 | €350,412 | -€67,264 | -16.1% |
| Financial charges | 65/66B | €2,158 | €3,529 | +€1,371 | +63.5% |
| Recurring financial charges | 65 | €2,158 | €3,529 | +€1,371 | +63.5% |
| Profit (loss) for the period before taxes | 9903 | €572,376 | €272,933 | -€299,443 | -52.3% |
| Income taxes | 67/77 | €154,014 | €33,870 | -€120,144 | -78.0% |
| Profit (loss) for the period | 9904 | €418,362 | €239,063 | -€179,299 | -42.9% |
| Profit (loss) for the period to be appropriated | 9905 | €418,362 | €239,063 | -€179,299 | -42.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.